N/A N=112 Coronavirus Disease of 2019 (COVID-19) Health Education Initiative for School Safety
COVID-19
Primary: Evaluation of Acceptability of Intervention as Measured by Acceptability Questionnaire — 4.47 score on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=245 Transmission of Coronavirus Disease 2019 (COVID19) in Crowded Environments
Covid19 · Sars-CoV-2 Infection
Primary: SARS-CoV-2 Infection — 4; 2 Participants
N/A N=4,142 COVID-19: Human Epidemiology and Response to SARS-CoV-2
Coronavirus Disease 2019 (COVID-19) · SARS-CoV-2
Primary: Number of Index Participants and Their Household Contacts With SARS-CoV-2 RNA Detection in Nasal Samples Over the Study/Surveillance Period — 98.9; 99.2; 99.1; 98.0…
N/A N=2,097 COVID-19 Watch + COVID-19 Pulse
Covid19
Primary: Difference in Days Alive and Out of Hospital — 29.5; 29.4 days
N/A N=1,102 Patients and Health Staff of Cancer Centres During the Covid-19 Pandemic
COVID-19
Primary: Number and Severity of Confirmed COVID-19 Infections Among Cancer Centre Staff and Patients at 12 Months — 55; 36 Participants
N/A N=2,778 You and Me COVID Free
COVID-19
Primary: Main Reason for Testing for COVID-19 — 1632; 493; 238; 343 Participants
N/A N=7,444 Mental and Physical Well-Being of Frontline Health Care Workers During Coronavirus Disease 2019 (COVID-19)
Healthy
Primary: PTSD Symptom Severity — 16.36; 17.10; 15.56; 15.78 score on a scale — p=.77
N/A N=118 Study to Evaluate Efficacy and Safety of "VIRACIDE" IN THE MANAGEMENT OF CORONA VIRUS DISEASE 2019 (COVID-19)
Covid19
Primary: Number of Participants With National Early Warning Score (NEWS) Change From 3 to 0 — 44; 29 Participants
N/A N=3,632 Epidemiological Study of the COVID-2019 in Participating Organizations.
Covid19
Primary: The Incidence of COVID-2019 Cases. — 259.95 COVID-2019 cases per 1000 person
N/A N=3 COVID-19 Close Contact Self-Testing Study
Covid19
Primary: Number of Positive Contacts — 0; 0 Participants
N/A N=69 Detection of SARS-CoV-2 RNA in Coughed Droplets From Patients With COVID-19
Covid19
Primary: Sensitivity of Detecting SARS-CoV-2 RNA — 31; 0 Participants
N/A N=172 Addressing COVID-19 Mental Health Problems Among US Veterans
Brief Video-based Intervention · Vignette Based Intervention · Non Intervention Control Arm
Primary: Help Seeking Intention — 7.4; 7.9; 7.3; 8.2 units on a scale — p=0.031
N/A N=309 Home-based Kidney Care in Native Americans of New Mexico (HBKC) - Enhancement: COVID-19 Study
CKD
Primary: Number of Participants With Problems in Their Health Care Due to COVID-19 Related Isolation — 155 Participants
N/A N=332 COVID-19 MP Biomedicals SARS-CoV-2 Ag OTC: Clinical Evaluation
SARS-CoV2 Infection · COVID-19
Primary: Positive Percent Agreement — 53; 2 Participants
N/A N=36 COVID-19 SARS-CoV-2 Screening Protocol
Covid19
Primary: Participants Enrolled — 36 Participants
N/A N=2,598 HIV-1 & Coronavirus-Coinfection in Europe: Morbidity & Risk Factors of COVID-19 in People Living With HIV
HIV-1-infection · COVID-19
Primary: Number of Composite Primary End Point (Critical Care Admission, Palliative Discharge When Discharged From Hospital, or Mortality Within the 6 Weeks After Diagnosis of…
N/A N=144 Mindfulness During COVID-19
Migraine Disorders · Stress · Anxiety
Primary: Helpfulness of the Session — 89 percentage of participants
N/A N=554 COVID-19 Treatment Cascade Optimization Study
COVID-19
Primary: Completion of COVID-19 Test — 72; 60 Participants
N/A N=10 First Responder Resiliency Program During COVID-19
Resilience · Stress · Sleep
Primary: Perceived Stress Scale — -3.2 units on a scale
N/A N=270 The Impact of the COVID-19 (SARS-CoV-2 Disease) on Psychopathology
Psychosis;Schizophrenic · Personality Disorders · Mood Disorders
Primary: Brief Psychiatric Rating Scale (BPRS) — 29.30; 32.80; 30.25 score on a scale
N/A N=93 Rapid, Onsite COVID-19 Detection
COVID-19 · Sars-CoV2
Primary: Number of Samples Tested — 3692 samples
N/A N=3,086 COVID-19: Healthy Oregon (Oregon Saludable): Together We Can (Juntos Podemos) Phase II
Health Behavior · Health Care Utilization
Primary: Testing Barriers and Hesitancy — 0.29; 0.24 score on a scale — p=0.09
N/A N=99 COVID-19 MP Biomedicals Rapid SARS-CoV-2 Antigen Test Usability
Sars-CoV-2 Infection · COVID-19
Primary: 30 Candidate Ag Test Self-collections — 53; 0 Participants
Phase 3 N=3,411 CROWN CORONATION: COVID-19 Research Outcomes Worldwide Network for CORONAvirus prevenTION
COVID 19
Primary: Number of Participants With Symptomatic COVID-19 at 60 Days — 24; 19 Participants — p=0.52
N/A N=74 Assess and Adapt to the Impact of COVID-19 on CVD Self-Management and Prevention Care in Adults Living With HIV
HIV-1-infection · Hypertension
Primary: Proportion of Eligible Participants Who Agree to Participate — 74 Participants
Phase 4 N=44 Studies of COVID-19 Patients Treated With Oral Bismuth Subsalicylate (Pepto-Bismol)
Diarrhea · COVID-19
Primary: Measure of Daily Stool Frequency for Patients With COVID Treated With Bismuth — 3 bowel movements
N/A N=822 Mobile Health and COVID-19
Anxiety Depression
Primary: Everyday Impairment — 15.65; 15.47; 12.74; 13.23 Scores on a scale
Phase 4 N=1,188 The Efficacy of the 2023-2024 Updated COVID-19 Vaccines Against COVID-19 Infection
COVID-19 · Vaccine-Preventable Diseases · SARS CoV 2 Infection
Primary: Number of Symptomatic SARS-CoV-2 Infections Between Randomized, Study-vaccinated Participants and the Comparator Group — 48; 94 Participants
N/A N=172 Evaluation of the Scleroderma Patient-centered Intervention Network COVID-19 Home-isolation Activities Together Program
Scleroderma · Scleroderma, Systemic · Systemic Sclerosis
Primary: Anxiety: Patient-Reported Outcomes Measurement Information System (PROMIS) Anxiety 4a v1.0 — 56.9; 58.8 T-score
N/A N=100 APT™ T3X on the COVID-19 Contamination Rate
COVID-19
Primary: COVID-19 Contamination Rate. — 2; 5 Participants